题名 | Gallic acid disruption of A beta(1-42) aggregation rescues cognitive decline of APP/PS1 double transgenic mouse |
作者 | |
通讯作者 | Hou, Sheng-Tao |
发表日期 | 2019-04
|
DOI | |
发表期刊 | |
ISSN | 0969-9961
|
EISSN | 1095-953X
|
卷号 | 124页码:67-80 |
摘要 | Alzheimer's disease (AD) treatment represents one of the largest unmet medical needs. Developing small molecules targeting A beta aggregation is an effective approach to prevent and treat AD. Here, we show that gallic acid (GA), a naturally occurring polyphenolic small molecule rich in grape seeds and fruits, has the capacity to alleviate cognitive decline of APP/PS1 transgenic mouse through reduction of A beta(1-42) aggregation and neurotoxicity. Oral administration of GA not only improved the spatial reference memory and spatial working memory of 4-month-old APP/PS1 mice, but also significantly reduced the more severe deficits developed in the 9-month-old APP/PS1 mice in terms of spatial learning, reference memory, short-term recognition and spatial working memory. The hippocampal long-term-potentiation (LTP) was also significantly elevated in the GA-treated 9-month-old APP/PS1 mice with increased expression of synaptic marker proteins. Evidence from atomic force microscopy (AFM), dynamic light scattering (DLS) and thioflavin T (ThT) fluorescence densitometry analyses showed that GA significantly reduces A beta(1-42) aggregation both in vitro and in vivo. Further, pre-incubating GA with oligomeric A beta(1-42) reduced A beta(1-42)-mediated intracellular calcium influx and neurotoxicity. Molecular docking studies identified that the 3,4,5-hydroxyle groups of GA were essential in noncovalently stabilizing GA binding to the Lys28-Ala42 salt bridge and the -COOH group is critical for disrupting the salt bridge of A beta(1-42). The predicated covalent interaction through Schiff-base formation between the carbonyl group of the oxidized product and epsilon-amino group of Lys16 is also critical for the disruption of A beta(1-42) S-shaped triple-beta-motif and toxicity. Together, these studies demonstrated that GA can be further developed as a drug to treat AD through disrupting the formation of A beta(1-42) aggregation. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 第一
; 通讯
|
资助项目 | SZDRC[K16205905]
|
WOS研究方向 | Neurosciences & Neurology
|
WOS类目 | Neurosciences
|
WOS记录号 | WOS:000459217800007
|
出版者 | |
ESI学科分类 | NEUROSCIENCE & BEHAVIOR
|
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:86
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/26159 |
专题 | 生命科学学院_生物系 理学院_化学系 |
作者单位 | 1.Southern Univ Sci & Technol, Brain Res Ctr, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China 2.Southern Univ Sci & Technol, Dept Biol, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China 3.Southern Med Univ, Key Lab Psychiat Disorders Guangdong Prov, Guangzhou 510515, Guangdong, Peoples R China 4.Southern Univ Sci & Technol, Dept Chem, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China |
第一作者单位 | 南方科技大学; 生物系 |
通讯作者单位 | 南方科技大学; 生物系 |
第一作者的第一单位 | 南方科技大学 |
推荐引用方式 GB/T 7714 |
Yu, Mei,Chen, Xuwei,Liu, Jihong,et al. Gallic acid disruption of A beta(1-42) aggregation rescues cognitive decline of APP/PS1 double transgenic mouse[J]. NEUROBIOLOGY OF DISEASE,2019,124:67-80.
|
APA |
Yu, Mei.,Chen, Xuwei.,Liu, Jihong.,Ma, Quan.,Zhuo, Zhan.,...&Hou, Sheng-Tao.(2019).Gallic acid disruption of A beta(1-42) aggregation rescues cognitive decline of APP/PS1 double transgenic mouse.NEUROBIOLOGY OF DISEASE,124,67-80.
|
MLA |
Yu, Mei,et al."Gallic acid disruption of A beta(1-42) aggregation rescues cognitive decline of APP/PS1 double transgenic mouse".NEUROBIOLOGY OF DISEASE 124(2019):67-80.
|
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | 操作 | |
Gallic acid disrupti(3757KB) | -- | -- | 限制开放 | -- |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论